Bioms Medical Corp

Premium Company Profile

Publication Date	April 2008
Publisher	Datamonitor
Product Type	Report
Pages	35
ISBN Number	not applicable
Product Code	DAT11468

Price

£265.00
approximately: $521 | €337

PDF

PRINT £315 ($619 | €400)

Order above formats by FAX

Summary

Introduction

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

BioMS Medical's lead candidate MBP8298 was licensed from University of Alberta. In addition, the company also licensed two technology platforms from the University of Alberta. One technology, HYC750, relates to the delivery of anti-viral and chemotherapy drugs into cells for the purpose of improving the effectiveness of those drugs. The other technology relates to the imaging of genes that have been delivered into cells as part of gene therapy treatment. Both technologies are at an early stage of development. BioMS Medical expects to increase its revenues from $81 million in 2008 to $134 million in 2010, primarily from the licensing and development agreement with Eli Lilly. As per the agreement, BioMS Medical would receive upfront payment in 2008.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization .

Content

Overview
Catalyst
Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Company Financials
- Stock Market Performance
- P&l
- Balance Sheet
- Cash Flow
- Products & Services
- Pipeline Products
- Ac Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Product Development
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table of Figures
- Figure 1: Bioms Medical- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table of Tables
- Table 1: Bioms Medical- Key Facts
- Table 2: Bioms Medical- Year-End Share Price and Market Capitalization, 2002-2006 (Cad$)
- Table 3: Bioms Medical- Key Events Impacting Share Price Performance
- Table 4: Bioms Medical- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 5: Bioms Medical- Operating Cost Ratio Analysis, 2002-2006 (% of Total Revenues)
- Table 6: Bioms Medical- Balance Sheet
- Table 7: Bioms Medical- Cash Flow
- Table 8: Bioms Medical- Collaboration Products
- Table 9: Bioms Medical- Forecast Sales, 2006-2010 ($ Mn)
- Table 10: Bioms Medical- Key Competitors
- Table 11: Bioms Medical- Key Suppliers
- Table 12: Bioms Medical- SWOT Analysis Summary
- Table 13: Bioms Medical- Value Chain Analysis
- Table 14: Bioms Medical- Key Employees
- Table 15: Bioms Medical - Financial and Operational Overview